Literature DB >> 9541509

Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.

M Spindler1, K W Saupe, M E Christe, H L Sweeney, C E Seidman, J G Seidman, J S Ingwall.   

Abstract

An arginine to glutamine missense mutation at position 403 of the beta-cardiac myosin heavy chain causes familial hypertrophic cardiomyopathy. Here we study mice which have this same missense mutation (alphaMHC403/+) using an isolated, isovolumic heart preparation where cardiac performance is measured simultaneously with cardiac energetics using 31P nuclear magnetic resonance spectroscopy. We observed three major alterations in the physiology and bioenergetics of the alphaMHC403/+ mouse hearts. First, while there was no evidence of systolic dysfunction, diastolic function was impaired during inotropic stimulation. Diastolic dysfunction was manifest as both a decreased rate of left ventricular relaxation and an increase in end-diastolic pressure. Second, under baseline conditions alphaMHC403/+ hearts had lower phosphocreatine and increased inorganic phosphate contents resulting in a decrease in the calculated value for the free energy released from ATP hydrolysis. Third, hearts from alphaMHC403/+ hearts that were studied unpaced responded to increased perfusate calcium by decreasing heart rate approximately twice as much as wild types. We conclude that hearts from alphaMHC403/+ mice demonstrate work load-dependent diastolic dysfunction resembling the human form of familial hypertrophic cardiomyopathy. Changes in high-energy phosphate content suggest that an energy-requiring process may contribute to the observed diastolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541509      PMCID: PMC508760          DOI: 10.1172/JCI1940

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions.

Authors:  J W Lawson; R L Veech
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

3.  High energy phosphate of the myocardium: concentration versus free energy change.

Authors:  H Kammermeier
Journal:  Basic Res Cardiol       Date:  1987       Impact factor: 17.165

4.  An improved procedure for serum creatine phosphokinase determination.

Authors:  S B Rosalki
Journal:  J Lab Clin Med       Date:  1967-04

Review 5.  The cytoplasmic phosphorylation potential. Its possible role in the control of myocardial respiration and cardiac contractility.

Authors:  C Gibbs
Journal:  J Mol Cell Cardiol       Date:  1985-08       Impact factor: 5.000

6.  Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells.

Authors:  P Hasty; R Ramírez-Solis; R Krumlauf; A Bradley
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

7.  Cytosolic phosphorylation potential.

Authors:  R L Veech; J W Lawson; N W Cornell; H A Krebs
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

8.  Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; P Spirito; K J Green; Y E Wesley; R O Bonow; J Arce
Journal:  J Am Coll Cardiol       Date:  1987-10       Impact factor: 24.094

9.  Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

Authors:  L Fananapazir; N D Epstein
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

10.  Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.

Authors:  B J Maron; W C Roberts; S E Epstein
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

View more
  76 in total

1.  Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Dan Chen; Libin Wang; Hiroko Wakimoto; Polakit Teekakirikul; Matthew Nayor; Masataka Kawana; Seda Eminaga; Joshua M Gorham; Kumar Pandya; Oliver Smithies; Francisco J Naya; Eric N Olson; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

Review 2.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

Review 3.  Cardiac spectroscopy: techniques, indications and clinical results.

Authors:  Meinrad Beer
Journal:  Eur Radiol       Date:  2004-03-06       Impact factor: 5.315

Review 4.  Hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

Review 5.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

6.  Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

Authors:  M A Sussman; S Welch; N Gude; P R Khoury; S R Daniels; D Kirkpatrick; R A Walsh; R L Price; H W Lim; J D Molkentin
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  Early remodeling of repolarizing K+ currents in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy.

Authors:  Rocco Hueneke; Adam Adenwala; Rebecca L Mellor; Jonathan G Seidman; Christine E Seidman; Jeanne M Nerbonne
Journal:  J Mol Cell Cardiol       Date:  2017-01-13       Impact factor: 5.000

8.  Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein.

Authors:  Eric J Jaehnig; Analeah B Heidt; Stephanie B Greene; Ivo Cornelissen; Brian L Black
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

9.  The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.

Authors:  Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Giulia D'Amati; Francesca Girolami; Magdi Yacoub; Franco Cecchi; Iacopo Olivotto; Corrado Poggesi
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

10.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.